Effects of Thyroxine Exposure on Osteogenesis in Mouse Calvarial Pre-Osteoblasts
Open Access
- 23 July 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (7) , e69067
Abstract
The incidence of craniosynostosis is one in every 1,800–2500 births. The gene-environment model proposes that if a genetic predisposition is coupled with environmental exposures, the effects can be multiplicative resulting in severely abnormal phenotypes. At present, very little is known about the role of gene-environment interactions in modulating craniosynostosis phenotypes, but prior evidence suggests a role for endocrine factors. Here we provide a report of the effects of thyroid hormone exposure on murine calvaria cells. Murine derived calvaria cells were exposed to critical doses of pharmaceutical thyroxine and analyzed after 3 and 7 days of treatment. Endpoint assays were designed to determine the effects of the hormone exposure on markers of osteogenesis and included, proliferation assay, quantitative ALP activity assay, targeted qPCR for mRNA expression of Runx2, Alp, Ocn, and Twist1, genechip array for 28,853 targets, and targeted osteogenic microarray with qPCR confirmations. Exposure to thyroxine stimulated the cells to express ALP in a dose dependent manner. There were no patterns of difference observed for proliferation. Targeted RNA expression data confirmed expression increases for Alp and Ocn at 7 days in culture. The genechip array suggests substantive expression differences for 46 gene targets and the targeted osteogenesis microarray indicated 23 targets with substantive differences. 11 gene targets were chosen for qPCR confirmation because of their known association with bone or craniosynostosis (Col2a1, Dmp1, Fgf1, 2, Igf1, Mmp9, Phex, Tnf, Htra1, Por, and Dcn). We confirmed substantive increases in mRNA for Phex, FGF1, 2, Tnf, Dmp1, Htra1, Por, Igf1 and Mmp9, and substantive decreases for Dcn. It appears thyroid hormone may exert its effects through increasing osteogenesis. Targets isolated suggest a possible interaction for those gene products associated with calvarial suture growth and homeostasis as well as craniosynostosis.Keywords
This publication has 56 references indexed in Scilit:
- Targeted Overexpression of Osteoactivin in Cells of Osteoclastic Lineage Promotes Osteoclastic Resorption and Bone Loss in MicePLOS ONE, 2012
- Epithelial–Mesenchymal Transition Induced by TNF-α Requires NF-κB–Mediated Transcriptional Upregulation of Twist1Cancer Research, 2012
- Differential Expression of Extracellular Matrix-Mediated Pathways in Single-Suture CraniosynostosisPLOS ONE, 2011
- Role of a Disordered Steroid Metabolome in the Elucidation of Sterol and Steroid BiosynthesisLipids, 2011
- Decorin is processed by three isoforms of bone morphogenetic protein-1 (BMP1)Biochemical and Biophysical Research Communications, 2010
- Twist1 homodimers enhance FGF responsiveness of the cranial sutures and promote suture closureDevelopmental Biology, 2008
- A Lack of Thyroid Hormones Rather than Excess Thyrotropin Causes Abnormal Skeletal Development in HypothyroidismMolecular Endocrinology, 2008
- Impaired posterior frontal sutural fusion in the biglycan/decorin double deficient miceBone, 2007
- Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCRBiological Procedures Online, 2006
- Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolismNature Genetics, 2006